Mount Sinai Center for Transformative Disease Modeling

Medicine & Life Sciences

1. Alzheimer Disease 100%
2. Brain 44%
3. Polyphenols 41%
4. Vitis 31%
5. Neuropathology 24%
6. Amyloid 21%
7. Gene Expression 21%
8. Grape Seed Extract 19%
9. Tauopathies 19%
10. Microglia 17%
11. Genes 16%
12. Genome 15%
13. Neurons 14%
14. Traumatic Brain Injury 13%
15. Neoplasms 12%
16. Proteomics 12%
17. Gene Regulatory Networks 12%
18. Cyclooxygenase 2 12%
19. Biomarkers 12%
20. Proteins 11%
21. Gastrointestinal Microbiome 11%
22. Transcriptome 11%
23. Mutation 11%
24. Dementia 10%
25. Transgenic Mice 10%
26. Phenotype 9%
27. Amyloid Precursor Protein Secretases 9%
28. Amyloidogenic Proteins 9%
29. phenolic acid 8%
30. Biological Availability 8%
31. Neurodegenerative Diseases 8%
32. Therapeutics 8%
33. Cognitive Dysfunction 7%
34. Astrocytes 7%
35. Catechin 7%
36. Pathology 7%
37. Induced Pluripotent Stem Cells 7%
38. Wine 7%
39. RNA Sequence Analysis 6%
40. Amyloid Plaques 6%
41. Synucleins 6%
42. Epigenomics 6%
43. Cognition 6%
44. Parkinson Disease 6%
45. Hippocampus 5%
46. Autophagy 5%
47. Breast Neoplasms 5%
48. Neuronal Plasticity 5%
49. Sex Characteristics 5%
50. Dietary Supplements 5%
51. Veterans 5%
52. Resveratrol 5%
53. Seeds 5%
54. Odorant Receptors 5%
55. Phosphorylation 5%
56. Oligonucleotide Array Sequence Analysis 5%
57. Cell Cycle 5%
58. Apolipoprotein E4 5%
59. Neuroglia 5%
60. Gene Expression Profiling 5%
61. Amyloid angiopathy 5%
62. Neoplasm Genes 5%
63. Memory 5%
64. Energy Metabolism 5%
65. Datasets 5%
66. Amyloid beta-Protein Precursor 5%
67. In Vitro Techniques 5%
68. Phosphotransferases 5%